Clinical trial
95475939ADM2001: 95475939ADM2001 Ph IIB Trial (N=210)
NCT06881251 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 95475939ADM2001: 95475939ADM2001 Ph IIB Trial (N=210)
- Lead sponsor
- Janssen Research & Development, LLC
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- February 26, 2025
- Completion date
- April 7, 2026
- Enrollment
- 256 (actual)
- Sites
- 71
Conditions
As the registry lists them; a condition with its own page is linked.